Armata Pharmaceuticals/$ARMP
1D1W1MYTD1Y5YMAX
Capital at risk
About Armata Pharmaceuticals
Armata Pharmaceuticals Inc is a late clinical-stage biotechnology company focused on the development of high-purity and potent, pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat bacterial infections using proprietary bacteriophage-based technology. It has completed three Phase 2 clinical trials to date. The Company operates and manages its business as one reportable operating segment, which is the business of developing pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat acute and chronic bacterial infections using its proprietary bacteriophage-based technology.
- Ticker
- $ARMP
- Sector
- Health
- Primary listing
- AMEX
- Employees
- 61
- Headquarters
- Los Angeles, United States
- Website
- www.armatapharma.com
ARMP Metrics
BasicAdvanced
$151M
-
-$5.27
1.33
-
Price and volume
Market cap
$151M
Beta
1.33
52-week high
$16.34
52-week low
$2.92
Average daily volume
274K
Financial strength
Current ratio
0.109
Quick ratio
0.106
Long term debt to equity
-0.293
Total debt to equity
-1.358
Interest coverage (TTM)
-1.65%
Profitability
EBITDA (TTM)
-33.448
Gross margin (TTM)
-217.36%
Net profit margin (TTM)
-3,467.04%
Operating margin (TTM)
-636.55%
Revenue per employee (TTM)
$90,000
Management effectiveness
Return on assets (TTM)
-25.83%
Return on equity (TTM)
127.83%
Valuation
Price to revenue (TTM)
26.775
Price to book
-0.65
Price to tangible book (TTM)
-0.62
Price to free cash flow (TTM)
-5.754
Free cash flow yield (TTM)
-17.38%
Free cash flow per share (TTM)
-0.707
Growth
Revenue change (TTM)
-19.29%
Earnings per share change (TTM)
290.22%
3-year revenue growth (CAGR)
10.00%
3-year earnings per share growth (CAGR)
72.27%
What the Analysts think about ARMP
Analyst ratings (Buy, Hold, Sell) for Armata Pharmaceuticals stock.
Analyst projections of the future price of Armata Pharmaceuticals stock.
ARMP Financial Performance
Revenues and expenses
ARMP Earnings Performance
Company profitability
Upcoming events
No upcoming events
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.